lunedì, 23 novembre 2020
Medinews
3 Dicembre 2018

ASCO and Friends of Cancer Research Applaud NCI’s Expansion of Clinical Trial Eligibility Criteria

November 29, 2018 – The American Society of Clinical Oncology, Inc. (ASCO) and Friends of Cancer Research (Friends) applaud the National Cancer Institute’s (NCI) recent revision of its clinical trial protocol template to broaden eligibility criteria for cancer clinical trials. The protocol template was expanded to help increase the opportunity for participation in NCI-funded clinical trials for patients with certain health care conditions, as well as to provide an opportunity for … (leggi tutto)

TORNA INDIETRO